Is enasidenib a long-term use?

Ensidipine (enasidenib) is an oral drug used to treat acute myeloid leukemia (AML), a cancer that starts in white blood cells (white blood cells), that has worsened or has relapsed after treatment with other chemotherapy drugs. Ensidipine belongs to a class of drugs called isocitrate dehydrogenase-2 (IDH2)inhibitors, which work by slowing or stopping the growth of cancer cells.

The recommended dose of ensidipine in the package insert is100mg orally once daily, with or without food, until disease progression or unacceptable toxicity occurs. For patients without disease progression or unacceptable toxicity, treat for at least 6 months to allow time for clinical response. Ensidipine is a targeted drug that needs to be taken long-term until drug resistance occurs.

A negative pregnancy test may be necessary before starting this treatment. Both men and women who use ensidipine should use birth control to prevent pregnancy. Ensidipine may harm an unborn baby if the mother or father is using this medication. Continue using birth control pills for at least 2 months after your last dose, and tell your doctor right away if you become pregnant. Do not breastfeed while taking this medicine, and at least2 months after your last injection. Follow all directions on your prescription label and read any medication guides or inserts carefully to use your medication as directed. Drink plenty of fluids while taking ensidipine. Take it at the same time every day, with or without food. Do not crush, chew, or breakensidipine tablets; swallow them whole. If you vomit soon after taking ensidipine, do not take another dose and take your next dose as planned. Store at room temperature, away from moisture and heat, in the original container with a hygroscopic preservative in the jar. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.

xa0